---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-249235"
form_type: "8-K"
ticker: "WHWK"
cik: "0001422142"
company_name: "Whitehawk Therapeutics, Inc."
filed_at: "2022-09-22T23:59:59+00:00"
generated_at: "2026-06-23T07:58:20.952772+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Aadi Bioscience raises $72.5M in PIPE financing to extend cash runway into 2025

## Summary
- PIPE includes 3,373,526 shares at $12.50 and 2,426,493 pre-funded warrants at $12.4999 with $0.0001 exercise price.
- Gross proceeds ~$72.5M; expected close Sept. 26, 2022, subject to customary conditions.
- Management participated for ~$750,000; led by a life sciences fund with existing investors.
- Proceeds to fund PRECISION 1 trial, FYARRO commercial efforts, and general working capital.
- Cash runway expected into 2025; preliminary PRECISION 1 data anticipated in H1 2023.

## SEC filing metadata
- accession: 0001193125-22-249235
- form_type: 8-K
- ticker: WHWK
- cik: 0001422142
- company_name: Whitehawk Therapeutics, Inc.
- filed_at: 2022-09-22T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1422142/000119312522249235/0001193125-22-249235-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1422142/000119312522249235/d367672d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-249235
- JSON: https://secwatch.observer/filing/0001193125-22-249235.json
- Plain text: https://secwatch.observer/filing/0001193125-22-249235.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.